Surface modified niosomes of olanzapine for brain targeting via nasal route; preparation, optimization, and in vivo evaluation

References

• Abbas, P., Jaleh, V., and Abdolhossein, R., 2007. In-vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. International journal of pharmaceutics, 328, 130–141.
   PubMed Web of Science ®Google Scholar
• Abdelbary, A., et al., 2016. Mucoadhesive niosomal in situ gel for oculartissue targeting: in vitro and in vivo evaluation of lomefloxacin hydrochloride. Pharmaceutical development and technology, 22, 409–417.
   PubMed Web of Science ®Google Scholar
• Abdel Mouez, M., et al., 2016. Composite chitosan-transfersomal vesicles for improved transnasalpermeation and bioavailability of verapamil. International journal of biomacromolecules, 93, 591–599.
   PubMed Web of Science ®Google Scholar
• Aboud, H.M., et al., 2015. Nanotransfersomes of carvedilol for intranasal delivery: formulation, characterization and in vivo evaluation. Drug Delivery, 23, 2471–2481.
   PubMed Web of Science ®Google Scholar
• Aboud, H.M., et al., 2018. Novel in situ gelling vaginal sponges of sildenafil citrate-based cubosomes for uterine targeting. Drug Delivery, 25 (1), 1328–1339.
   PubMed Web of Science ®Google Scholar
• Abraham Lingan, M., et al., 2011. Formulation and evaluation of topical drug delivery system containing clobetasol propionate niosomes. Scientific reviews and chemical communications, 1, 7–17.
   Google Scholar
• Ayala, A.P., et al., 2006. Solid state characterization of olanzapine polymorphs using vibrational spectroscopy. International journal of pharmaceuticals, 326 (1–2), 69–79.
   PubMed Web of Science ®Google Scholar
• Azeem, A., et al., 2008. Nonionic surfactant vesicles as a carrier for transdermal delivery of frusemide. Journal of dispersion and science technology, 29 (5), 723–730.
   Web of Science ®Google Scholar
• Baltzley, S., et al., 2014. Intranasal drug delivery of olanzapine-loaded chitosan nanoparticles. AAPS PharmSciTech, 15 (6), 1598–1602.
   PubMed Web of Science ®Google Scholar
• Bayindir, Z.S. and Yuksel, N., 2010. Characterization of niosomes prepared with various nonionic surfactants for paclitaxel oral delivery. Journal of pharmaceutical sciences, 99 (4), 2049–2060.
   PubMed Web of Science ®Google Scholar
• Casettari, L. and Illum, L., 2014. Chitosan in nasal delivery systems for therapeutic drugs. Journal of controlled release: official journal of the controlled release society, 190, 189–200.
   PubMed Web of Science ®Google Scholar
• Costantino, H.R., et al., 2007. Intranasal delivery: physicochemical and therapeutic aspects. International journal of pharmaceuticals, 337 (1–2), 1–24.
   PubMed Web of Science ®Google Scholar
• De Campos, A.M., Sánchez, A., and Alonso, M.J., 2001. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. International journal of pharmaceuticals, 224 (1–2), 159–168.
   PubMed Web of Science ®Google Scholar
• El-Nabarawi, M.A., et al., 2016. Transbuccal delivery of betahistine dihydrochloride from mucoadhesive tablets with a unidirectional drug flow: in vitro, ex vivo and in vivo evaluation. Drug design, development and therapy, 10, 4031–4045.
   PubMed Web of Science ®Google Scholar
• Fuller, M.A., et al., 2003. Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine. Pharmacotherapy, 23 (8), 1037–1043.
   PubMed Web of Science ®Google Scholar
• Ghirardelli, R., et al., 1999. Identification of particular epithelial areas and cells that transport polypeptidecoated nanoparticles in the nasal respiratory mucosa of the rabbit. Biochimica et biophysica acta, 1416 (1–2), 39–47.
   PubMed Web of Science ®Google Scholar
• Gianasi, E., et al., 1997. Pharmaceutical and biological characterization of a doxorubicin-polymer conjugate (PK1) entrapped in sorbitan monostearate Span 60 niosomes. International journal of pharmaceutics, 148 (2), 139–148.
   Web of Science ®Google Scholar
• Hao, Y., et al., 2002. Studies on a high encapsulation of colchicine by niosome system. International journal of pharmaceutics, 244 (1–2), 73–80.
   PubMed Web of Science ®Google Scholar
• Junyaprasert, V.B., Teeranachaideekul, V., and Supaperm, T., 2008. Effect of charged and non-ionic membrane additives on physicochemical properties and stability of niosomes. AAPS pharmscitech, 9, 851–859.
   PubMed Web of Science ®Google Scholar
• Kamboj, S., Saini, V., and Bala, S., 2014. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement. The scientific world journal, 2014, 1.
   Web of Science ®Google Scholar
• Khallaf, R.A., Salem, H.F., and Abdelbary, A., 2016. 5-Fluorouracil shell-enriched solid lipid nanoparticles (SLN) for effective skin carcinoma treatment. Drug Delivery, 23 (9), 3452–3460.
   PubMed Web of Science ®Google Scholar
• Khan, S., et al., 2009. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats. Journal of pharmacy and pharmacology, 61 (5), 669–675.
   PubMed Web of Science ®Google Scholar
• Maher, E.M., et al., 2016. In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine co-amorphous dispersion with selected carboxylic acids. Drug Delivery, 23 (8), 3088–3100.
   PubMed Web of Science ®Google Scholar
• Mahmoud, M.O., et al., 2017. Transdermal delivery of atorvastatin calcium from novel nanovesicular systems using polyethylene glycol fatty acid esters: ameliorated effect without liver toxicity in poloxamer 407-induced hyperlipidemic rats. Journal of controlled release, 254, 10–22.
   PubMed Web of Science ®Google Scholar
• Manosroi, A., Jantrawut, P., and Manosroi, J., 2008. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. International journal of pharmaceutics, 360 (1–2), 156–163.
   PubMed Web of Science ®Google Scholar
• Marttin, E., et al., 1997. Confocal laser scanning microscopic visualization of the transport of dextran after nasal administration to rats: effects of absorption enhancers. Pharmaceutical research, 14 (5), 631–637.
   PubMed Web of Science ®Google Scholar
• Moghassemi, S. and Hadjizadeh, A., 2014. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. Journal of controlled release: official journal of the controlled release society, 185, 22–36.
   PubMed Web of Science ®Google Scholar
• Montgomery, W., et al., 2012. Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties. Patient prefer adherence, 6, 109–125.
   PubMed Web of Science ®Google Scholar
• Owen, R.R., et al., 1996. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric services (Washington, D.C.), 47 (8), 853–858.
   PubMed Web of Science ®Google Scholar
• Ranga, P.M., Natarajan, R., and Rajendran, N.N., 2013. Formulation and evaluation of zidovudine loaded niosomes. Journal of pharmaceutical nanotechnology, 1, 12–18, 39–40.
   Google Scholar
• Rangasamy, S., et al., 2008. Formulation and in vivo evaluation of niosomes encapsulated acyclovir. Journal of pharmaceutical research, 1, 163–166.
   Google Scholar
• Rassu, G., et al., 2018. The role of combined penetration enhancers in nasal microspheres on in vivo drug bioavailability. Pharmaceutics, 10 (4), 206.
   PubMed Web of Science ®Google Scholar
• Ruckmani, K. and Sankar, V., 2010. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech, 11 (3), 1119–1127.
   PubMed Web of Science ®Google Scholar
• Salama, H.A., et al., 2012. Phospholipid based colloidal poloxamer–nanocubic vesicles for brain targeting via the nasal route. Colloids and surfaces B: biointerfaces, 100, 146–154.
   PubMed Web of Science ®Google Scholar
• Seager, H., 1998. Drug-delivery products and the Zydis fast-dissolving dosage form. Journal of pharmacy and pharmacology, 50 (4), 375–382.
   PubMed Web of Science ®Google Scholar
• Seju, U., Kumar, A., and Sawant, K.K., 2011. Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta biomaterialia, 7 (12), 4169–4176.
   PubMed Web of Science ®Google Scholar
• Simon, V., van Winkel, R., and De Hert, M., 2009. Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review. The journal of clinical psychiatry, 70 (7), 1041–1050.
   PubMed Web of Science ®Google Scholar
• Sinswat, P. and Tengamnuay, P., 2003. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins. International journal of pharmaceuticals, 257 (1–2), 15–22.
   PubMed Web of Science ®Google Scholar
• Sood, S., et al., 2013. Olanzapine loaded cationic solid lipid nanoparticles for improved oral bioavailability. Current Nanoscience, 9, 26–34.
   Web of Science ®Google Scholar
• Thomas, P., et al., 2009. Management of patients presenting with acute psychotic episodes of schizophrenia. CNS Drugs, 23 (3), 193–212.
   PubMed Web of Science ®Google Scholar
• Vanputten, T., 1978. Drug refusal in schizophrenia—causes and prescribing hints. Hospital and community psychiatry, 29, 110–112.
   PubMedGoogle Scholar
• Wilson, J.D. and Enoch, M.D., 1967. Estimation of drug rejection by schizophrenic in-patients with analysis of clinical factors. British journal of psychiatry, 113 (495), 209–211.
   PubMed Web of Science ®Google Scholar
• Yood, M.U., et al., 2011. Association between second-generationantipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose? BMC psychiatry, 11, 197.
   PubMed Web of Science ®Google Scholar
• Zaki, N.M., et al., 2007. Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesive in situ gel with modulated rheological and mucociliary transport properties. European journal of pharmaceutical sciences, 32 (4–5), 296–307.
   PubMed Web of Science ®Google Scholar
• Zhang, Q., et al., 2004. Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. International journal of pharmaceutics, 275 (1–2), 85–96.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2010. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Computer methods and programs in biomedicine, 99 (3), 306–314.
   PubMed Web of Science ®Google Scholar